title: The new vitamin E derivative, ETS-GS, protects against cecal ligation and puncture-induced systemic inflammation in rats.
abstract: Sepsis-related systemic inflammation frequently occurs in the critical care setting. Systemic inflammation is implicated in the progression of organ injury, which is associated with a high mortality rate. Recently, vitamin E and glutamic acid have been reported to attenuate inflammation. We therefore investigated whether the vitamin E derivative, ETS-GS, could inhibit the secretion of cytokines and high-mobility group box 1 (HMGB1), and thereby reduce organ damage in a rat model of cecal ligation and puncture (CLP)-induced sepsis. Male Wistar rats weighing 250-300 g were used. Rats received water or ETS-GS (10 mg/kg) by oral administration for 3 weeks, and then sepsis was induced by CLP under sevoflurane anesthesia. Serum levels of interleukin-6, tumor necrosis factor-α, and HMGB1 were determined at 3, 6, and 12 h after CLP; lung histology was assessed at 12 h. Histology results showed markedly reduced interstitial edema and leukocytic infiltration in lung tissue harvested at 12 h in ETS-GS-treated mice compared with untreated controls. ETS-GS treatment also attenuated the CLP-induced increase in serum levels of cytokines and HMGB1. To investigate the mechanisms by which ETS-GS exerts its anti-inflammatory effects, the phosphorylation of Akt, IκBα, and mitogen-activated protein kinase (MAPK) was assessed in mouse macrophage RAW264.7 cells stimulated with LPS, with and without ETS-GS. In these in vitro studies, ETS-GS-induced phosphoinositide 3-kinase (PI3K)-Akt phosphorylation and inhibited IκBα and MAPK phosphorylation. ETS-GS blocked the CLP-induced septic shock response and protected against acute lung injury. This mechanism appeared to be mediated by the induction of PI3K-Akt and the inhibition of IκBα and MAPK phosphorylation. Given these results, ETS-GS shows promise as a potential therapeutic agent for sepsis.
authors: Department of Anesthesiology and Intensive Care Medicine, Oita University Faculty of Medicine, 1-1 Idaigaoka-Hasamamachi, Yufu City, Oita 879-5593, Japan.
authors: Hironori
authors: H
authors: Koga
authors: Satoshi
authors: S
authors: Hagiwara
authors: Masafumi
authors: M
authors: Inomata
authors: Youhei
authors: Y
authors: Kono
authors: Yoshimasa
authors: Y
authors: Oyama
authors: Shinya
authors: S
authors: Kai
authors: Taichi
authors: T
authors: Nishida
authors: Takayuki
authors: T
authors: Noguchi
references: Shock. 2002 Sep;18(3):236-41
references: 12353924
references: Crit Care Med. 2001 Jul;29(7):1303-10
references: 11445675
references: Science. 1999 Jul 9;285(5425):248-51
references: 10398600
references: Physiol Rev. 2001 Apr;81(2):807-69
references: 11274345
references: Recent Pat Inflamm Allergy Drug Discov. 2009 Jun;3(2):96-112
references: 19519586
references: Crit Care Med. 2007 Sep;35(9 Suppl):S591-5
references: 17713414
references: J Surg Res. 2011 Nov;171(1):226-33
references: 20451924
references: Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1768-73
references: 11734424
references: J Pathol. 2004 Feb;202(2):145-56
references: 14743496
references: Curr Opin Cell Biol. 1998 Apr;10(2):262-7
references: 9561851
references: J Clin Invest. 2003 Aug;112(4):460-7
references: 12925683
references: J Immunol. 2008 Mar 15;180(6):4218-26
references: 18322234
references: Crit Care Med. 2001 Jul;29(7 Suppl):S99-106
references: 11445742
references: Annu Rev Immunol. 2000;18:621-63
references: 10837071
references: Toxicology. 2006 Aug 1;225(1):36-47
references: 16793190
references: Surgery. 1999 Aug;126(2):389-92
references: 10455911
references: FEBS Lett. 1993 Apr 26;321(2-3):215-8
references: 7682975
references: Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1538-44
references: 17652366
references: Crit Care Med. 2000 Oct;28(10):3405-11
references: 11057793
references: J Toxicol Environ Health A. 2005 Dec 10;68(23-24):2051-62
references: 16326423
references: J Appl Physiol (1985). 2007 Jul;103(1):388-95
references: 17303713
references: J Immunol. 1999 May 15;162(10):6184-90
references: 10229863
references: Crit Care Med. 1999 Jul;27(7):1230-51
references: 10446814
references: Shock. 2010 Mar;33(3):282-8
references: 19536047
references: Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8
references: 16481882
references: Nature. 1997 Aug 7;388(6642):548-54
references: 9252186
references: Intensive Care Med. 2008 Feb;34(2):361-7
references: 17940748
references: Chest. 2003 May;123(5 Suppl):451S-9S
references: 12740228
references: Amino Acids. 2008 Aug;35(2):403-10
references: 18163178
references: Inflammation. 2010 Apr;33(2):126-36
references: 20238486